You searched for Antibody candidate - Page 68 of 69

In Depth 5 Dec 2022

The biggest private biotech investments in November 2022

…cheaply. Second place went to CatalYm in Germany. The firm specializes in the development of anti-cancer antibodies and is testing its lead candidate in clinical trials. Topping the healthcare biotech…

December 5, 2022 - 4 minutesmins - By Jonathan Smith

In Depth 26 Jun 2024

Biotech megadeals: Exploring the surge in $100M+ deals

…molecule therapies driving megadeals in the biotech industry. “The Inflation Reduction Act granted large molecule therapies (gene and protein-based therapies, immunotherapies, hormonal regulators, and antibody-drug conjugates), a much longer patent…

June 26, 2024 - 9 minutesmins - By Jules Adam

News and Trends 22 Jan 2018

Novartis Takes Genmab’s Leukemia Drug Off the Market

…a monoclonal antibody that targets CD20 proteins on the surface of leukemia cells. The antibody binds to the proteins, alerting the immune system, which can then hunt down and kill…

January 22, 2018 - 3 minutesmins - By Alex Dale

News and Trends 17 Nov 2016

Find Out what’s Hot in the Latin American Biotech scene

…and antibody specificity testing. In these areas, it has developed its MTB Array for Tuberculosis Proteome Microarray and FastMAb for custom antibody development. CDI is also pursuing a Protein Capture…

November 17, 2016 - 4 minutesmins - By External Contributor

Interview 12 Apr 2017

Video Interview: How Morphosys Grew Into a Billion-Euro Biotech

…biotech in Germany, Morphosys. Their topics ranged from Morphosys’ current pipeline and previous failures to the immuno-oncology hype and company culture. Morphosys started out with its proprietary antibody technology platform…

April 12, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 5 Feb 2016

Biotech of the week: Effimune, the French Success-story in autoimmune disease

…with it’s primary focus on the research and development of drug candidates for transplant and immune-mediated diseases, making it one of the largest EU research and clinical centers in transplant…

February 5, 2016 - 2 minutesmins - By Philip Hemme

News and Trends 22 Jan 2018

Abcam Will Start Selling Over 700 Antibodies from Roche

…to over 500 other antibodies. And, as Spring continues developing new antibodies, the antibody seller will have the rights to all products that Roche decides to commercialize. For its part,…

January 22, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

How to Address the Challenges of Biologics Discovery and Development

…key market players enter the field, competition is increasing. In recent years, the biologics industry has become more versatile and has moved from being primarily antibody-focused to including other modalities,…

November 27, 2019 - 6 minutesmins - By External Contributor

News and Trends 12 Dec 2022

OSE Immunotherapeutics announces latest acute lymphoblastic leukemia data

…to its dual mode of action comprising both antibody-dependent cellular phagocytosis induction and IL-7R-pathway blockade, OSE-127 may represent a promising novel immunotherapy option for ALL patients, including cases with dysregulated…

December 12, 2022 - 4 minutesmins - By Jim Cornall

Interview 6 Mar 2017

How did this Biotech seal a €1B Deal with AstraZeneca? The CEO Explains

…use bicyclic peptides to guide toxins in an approach similar to antibody-drug conjugates (ADCs); and they stand to outperform their antibody-guided counterparts. Kevin Lee, CEO of Bicycle Therapeutics, sat down…

March 6, 2017 - 7 minutesmins - By Evelyn Warner

News and Trends 29 May 2020

Argenx Follows up Phase III Success with Giant €785M Global Offering

…III trial results earlier this week, where its lead candidate antibody drug, efgartigimod, improved motor symptoms of patients with the chronic autoimmune disease myasthenia gravis. Argenx is listed on the…

May 29, 2020 - 2 minutesmins - By Jonathan Smith

Best in Biotech 26 Dec 2017

Interviews, Reviews and Tops: Our Best Biotech Articles from 2017

…of approaches… https://www.labiotech.eu/tag/mrna-technology/ RNA saw its first major win in perhaps decades this year, with the positive Phase III results for Alnylam and Sanofi‘s candidate, patisiran. So how far has…

December 26, 2017 - 6 minutesmins - By Evelyn Warner

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

The biggest private biotech investments in November 2022

Biotech megadeals: Exploring the surge in $100M+ deals

Novartis Takes Genmab’s Leukemia Drug Off the Market

Find Out what’s Hot in the Latin American Biotech scene

Video Interview: How Morphosys Grew Into a Billion-Euro Biotech

Biotech of the week: Effimune, the French Success-story in autoimmune disease

Abcam Will Start Selling Over 700 Antibodies from Roche

How to Address the Challenges of Biologics Discovery and Development

OSE Immunotherapeutics announces latest acute lymphoblastic leukemia data

How did this Biotech seal a €1B Deal with AstraZeneca? The CEO Explains

Argenx Follows up Phase III Success with Giant €785M Global Offering

Interviews, Reviews and Tops: Our Best Biotech Articles from 2017

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!